Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The application of MSC-derived secretome has been studied towards different pathologies by counteracting inflammation while inducing tissue regeneration namely in lung, hepatic and brain tissues.”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
In the citing paper
“Nevertheless, this cell-free approach has also been reported with beneficial effects for other pathologies, including bone tissue, cardiovascular, intestinal and renal diseases [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170] (Table 2).”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
Citations
Cites
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., Entman, M. L., Michael, L. H., Hirschi, K. K., & Goodell, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12150 · Cited by 1,960
Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., & Dzau, V. J. (2003) · Nature Medicine · doi:10.1038/nm912 · Cited by 1,509
Self-citationKajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Nygren, J. M., Jovinge, S., Breitbach, M., Säwén, P., Röll, W., Hescheler, J., Taneera, J., Fleischmann, B. K., & Jacobsen, S. E. W. (2004) · Nature Medicine · doi:10.1038/nm1040 · Cited by 1,037
Friedrich, J. O., Apstein, C. S., & Ingwall, J. S. (1995) · Circulation · doi:10.1161/01.cir.92.12.3527 · Cited by 43
Self-citation
Research works printed but not linked: 3
- Tomita, S. et al. Circulation 100 (19 Suppl), II247–56 (1999).
- Gnecchi, M. et al. Circulation 110 (17 Suppl), III249 (2004).
- Kajstura, J. et al. Lab. Invest. 74, 86–107 (1996).
Cited by
Items 301–400 of 1,000
Emerging understanding of apoptosis in mediating mesenchymal stem cell therapy
Fu, Y., Sui, B., Xiang, L., Yan, X., Wu, D., Shi, S., & Hu, X. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03883-6 · Cited by 101
Kuhlmann, M. T., Kirchhof, P. F., Klocke, R., Hasib, L., Stypmann, J., Fabritz, L., Stelljes, M., Tian, W., Zwiener, M., Mueller, M., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051151 · Cited by 110
UC blood-derived mesenchymal stromal cells: an overview
Flynn, A. W., Barry, F., & O’Brien, T. (2007) · Cytotherapy · doi:10.1080/14653240701584578 · Cited by 109
Li, J. H., Zhang, N., & Wang, J. A. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345575 · Cited by 108
Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds?
Domenech, M., Polo-Corrales, L., Ramirez-Vick, J. E., & Freytes, D. O. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2015.0523 · Cited by 101
“between the stem cell and endogenous cardiac myocytes,(32) and (3) release of paracrine factors that stimulate endogenous cardiac repair mechanisms.(33,34) Conflicting results showing a lack of transdifferentiation have put into question its role in cardiomyoplasty and motivated the search of alternative hypotheses li…”
Yamahara, K., Harada, K., Ohshima, M., Ishikane, S., Ohnishi, S., Tsuda, H., Otani, K., Taguchi, A., Soma, T., Ogawa, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088319 · Cited by 107
Akt Promotes Increased Cardiomyocyte Cycling and Expansion of the Cardiac Progenitor Cell Population
Gude, N. A., Muraski, J. A., Rubio, M., Kajstura, J., Schaefer, E., Anversa, P., & Sussman, M. A. (2006) · Circulation Research · doi:10.1161/01.res.0000236754.21499.1c · Cited by 107
Potential Clinical Applications of Stem Cells in Regenerative Medicine
Suman, S., Domingues, A., Ratajczak, J., & Ratajczak, M. Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-31206-0_1 · Cited by 110
Engineered Extracellular Vesicles: Tailored-Made Nanomaterials for Medical Applications
Man, K., Brunet, M. Y., Jones, M., & Cox, S. C. (2020) · Nanomaterials · doi:10.3390/nano10091838 · Cited by 111
“Many of the beneficial effects once accredited to cell-based therapies are now believed to be attributed in some degree to the paracrine cargo packaged within EVs [15,16].”
BackgroundXenotransplantation of Long-Term-Cultured Swine Bone Marrow-Derived Mesenchymal Stem Cells
Nakamura, Y., Wang, X., Xu, C., Asakura, A., Yoshiyama, M., From, A. H. L., & Zhang, J. J. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0168 · Cited by 106
Skeletal myoblasts and cardiac repair
Menasché, P. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.11.009 · Cited by 106
Liu, W., Li, R., Yin, J., Guo, S., Chen, Y., Fan, H., Li, G., Li, Z., Li, X., Zhang, X., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1396-5 · Cited by 80
Ishikane, S., Ohnishi, S., Yamahara, K., Sada, M., Harada, K., Mishima, K., Iwasaki, K., Fujiwara, M., Kitamura, S., Nagaya, N., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0236 · Cited by 110
Miki, K., Uenaka, H., Saito, A., Miyagawa, S., Sakaguchi, T., Higuchi, T., Shimizu, T., Okano, T., Yamanaka, S., & Sawa, Y. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0038 · Cited by 103
Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration
Emmert, M. Y., Hitchcock, R. W., & Hoerstrup, S. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.004 · Cited by 109
Gene therapy for ischemic heart disease
Lavu, M., Gundewar, S., & Lefer, D. J. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.06.007 · Cited by 115
“Transplanted MSCs modified to express Akt were resistant to apoptosis [72], attenuated remodeling [73] and were found to have anti-apoptotic actions on distant ischemic myocardial cells away from their sites of injection[74].”
BackgroundCho, J., Zhai, P., Maejima, Y., & Sadoshima, J. (2011) · Circulation Research · doi:10.1161/circresaha.110.229658 · Cited by 102
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Triana-Martínez, F., Loza, M. I., & Domínguez, E. (2020) · Cells · doi:10.3390/cells9020346 · Cited by 105
“MCS exhibits a physiological secretome mainly composed of HGF, TGF-β, CCL2/5, IL-6, VEGF, TSG-6, PGE2, and galectins 1/9 ([186] and reviewed in [187]), an anti-inflammatory environment protective against proinflammatory stimuli like INF-γ [188] or in 3D conditions [189].”
BackgroundTran, S. D., Liu, Y., Xia, D., Maria, O. M., Khalili, S., Wang, R. W.-J., Quan, V.-H., Hu, S., & Seuntjens, J. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061632 · Cited by 104
“The demonstration that injecting conditioned medium from MSC cultures exerted cardiomyocyte protection and improved cardiac function in mouse infarcted hearts provided an elegant proof of concept [49,50].”
BackgroundZiebart, T., Yoon, C., Trepels, T., Wietelmann, A., Braun, T. W., Kiessling, F. M., Stein, S., Grez, M., Ihling, C. H., Muhly-Reinholz, M., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.180463 · Cited by 101
Application of Stem Cells in Orthopedics
Schmitt, A., van Griensven, M., Imhoff, A. B., & Buchmann, S. (2012) · Stem Cells International · doi:10.1155/2012/394962 · Cited by 112
Mohr, A., Albarenque, S. M., Deedigan, L., Yu, R., Reidy, M., Fulda, S., & Zwacka, R. M. (2010) · Stem Cells · doi:10.1002/stem.533 · Cited by 97
Cell Therapy of Acute Myocardial Infarction: Open Questions
Dimmeler, S., & Zeiher, A. M. (2008) · Cardiology · doi:10.1159/000187652 · Cited by 100
“] or by perivascular accumulation of cells and subsequent delivery of growth factors and cytokines [ , ,”
BackgroundCardiac stem cell therapy to modulate inflammation upon myocardial infarction
van den Akker, F., Deddens, J. C., Doevendans, P. A., & Sluijter, J. P. G. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.08.026 · Cited by 105
Modularized Extracellular Vesicles: The Dawn of Prospective Personalized and Precision Medicine
Tao, S., Guo, S., & Zhang, C. (2018) · Advanced Science · doi:10.1002/advs.201700449 · Cited by 100
Concise Review: Rational Use of Mesenchymal Stem Cells in the Treatment of Ischemic Heart Disease
Ward, M. R., Abadeh, A., & Connelly, K. A. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0210 · Cited by 109
Yeghiazarians, Y., Zhang, Y., Prasad, M., Shih, H., Saini, S. A., Takagawa, J., Sievers, R. E., Wong, M. L., Kapasi, N. K., Mirsky, R. S., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.85 · Cited by 99
Current Stem Cell Delivery Methods for Myocardial Repair
Sheng, C. C., Zhou, L., & Hao, J. (2012) · BioMed Research International · doi:10.1155/2013/547902 · Cited by 99
“Unlike the surgical approach, catheter-based intramyocardial injection can be extended to surgically high-risk patients and be repeated if necessary because of its less invasive nature.”
BackgroundA New Era of Cardiac Cell Therapy: Opportunities and Challenges
Huang, K., Hu, S., & Cheng, K. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201801011 · Cited by 103
Webber, M. J., Han, X., Murthy, S. N. P., Rajangam, K. L., Stupp, S. I., & Lomasney, J. W. (2010) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.273 · Cited by 98
“More recently, this has led others to postulate that the mechanism for stem cell transplant efficacy, particularly in the heart, is paracrine factor-linked (Gnecchi et al., 2005; Pittenger and Martin, 2004; Tang et al., 2004, 2005; Zhang et al., 2007).”
BackgroundMesenchymal Stem Cells for Cardiac Regenerative Therapy
Schuleri, K. H., Boyle, A., & Hare, J. M. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-68976-8_9 · Cited by 104
Madonna, R., Taylor, D. A., Geng, Y., Caterina, R. D., Shelat, H. S., Perin, E. C., & Willerson, J. T. (2013) · Circulation Research · doi:10.1161/circresaha.113.301690 · Cited by 99
“anism by which stem cells improve repair in ischemic tissues.(31,32) To evaluate the potential paracrine capacity of MSCs”
BackgroundStem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise
Duelen, R., & Sampaolesi, M. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.029 · Cited by 106
Peripheral blood mononuclear cell secretome for tissue repair
Beer, L., Mildner, M., Gyöngyösi, M., & Ankersmit, H. (2016) · Apoptosis · doi:10.1007/s10495-016-1292-8 · Cited by 88
Rasmussen, J. G., Fröbert, O., Holst‐Hansen, C., Kastrup, J., Baandrup, U. T., Zachar, V., Fink, T., & Simonsen, U. (2013) · Cell Transplantation · doi:10.3727/096368912x659871 · Cited by 96
“Paracrine effects of the transplanted cells plays a major role in preserving cardiac function (11,28,44), and induction of angiogenesis as well as a strengthened scar area are often reported (5,37).”
BackgroundHu, J.-C. E., Zheng, C., Sui, B., Liu, W., & Jin, Y. J. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i5.318 · Cited by 105
Stem Cell Engraftment and Survival in the Ischemic Heart
Wu, K. H., Mo, X. M., Han, Z., & Zhou, B. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.07.012 · Cited by 101
Mesenchymal Stem Cells in Cancer
Stagg, J. (2008) · Stem Cell Reviews and Reports · doi:10.1007/s12015-008-9030-4 · Cited by 103
“In the context of myocardium regeneration for instance, it has been proposed that trophic factors secreted by MSCs are mainly responsible for their therapeutic effects after cardiac infarction [9].”
BackgroundXiong, Q., Ye, L., Zhang, P., Lepley, M. A., Swingen, C., Zhang, L., Kaufman, D. S., & Zhang, J. J. (2012) · Circulation Research · doi:10.1161/circresaha.112.269894 · Cited by 95
Self-citationBian, W., & Bursac, N. (2008) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/memb.2008.928460 · Cited by 96
Cell secretome: basic insights and therapeutic opportunities for CNS disorders
Pinho, A. G., Cibrão, J. R., Silva, N. A., Monteiro, S., & Salgado, A. J. (2020) · Pharmaceuticals · doi:10.3390/ph13020031 · Cited by 94
Kim, J. H., Park, D. J., Yun, J. C., Jung, M. H., Yeo, H. D., Kim, H., Kim, D. W., Yang, J. I., Lee, G., Jeong, S., et al. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00060.2011 · Cited by 97
“Indeed, numerous studies have shown that organ protection by administered stem cells is primarily due to paracrine mechanisms rather than the replacement of damaged cells by differentiated stem cells (9, 21, 22, 40).”
BackgroundSuzuki, G., Iyer, V., Lee, T., & Canty, J. M. (2011) · Circulation Research · doi:10.1161/circresaha.111.245969 · Cited by 102
Mesenchymal stem cells and vascular regeneration
Gu, W., Hong, X., Potter, C. M. F., Qu, A., & Xu, Q. (2016) · Microcirculation · doi:10.1111/micc.12324 · Cited by 98
The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth
Han, Z., Jing, Y., Zhang, S., Liu, Y., Shi, Y., & Wei, L. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-8 · Cited by 101
“MSCs transplantation is also regarded as a useful therapeutic strategy in acute tissue injuries of the lung[74], heart[75] and liver[76-78].”
BackgroundAging of mesenchymal stem cells: Implication in regenerative medicine
Yang, Y.-H. K. (2018) · Regenerative Therapy · doi:10.1016/j.reth.2018.09.002 · Cited by 98
“For example, conditioned media derived from unmodified [12,13] or Akt-modified [14] MSCs have been shown to contain paracrine factors that contribute to myocardial protection from ischemic injury.”
BackgroundSaha, P., Sharma, S., Korutla, L., Datla, S. R., Shoja‐Taheri, F., Mishra, R., Bigham, G. E., Sarkar, M., Morales, D., Bittle, G. J., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau1168 · Cited by 95
Preconditioning of Stem Cells by Oxytocin to Improve Their Therapeutic Potential
Noiseux, N., Borie, M., Desnoyers, A., Menaouar, A., Stevens, L. M., Mansour, S., Danalache, B. A., Roy, D.-C., Jankowski, M., & Gutkowska, J. (2012) · Endocrinology · doi:10.1210/en.2012-1402 · Cited by 86
Self-citationCardiac repair and regeneration: the Rubik’s cube of cell therapy for heart disease
Boudoulas, K. D., & Hatzopoulos, A. K. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.000240 · Cited by 100
“This ‘cell-help-cell’ effect is enhanced further when MSCs are engineered to express the pro-survival kinase Akt1 (Mangi et al., 2003; Gnecchi et al., 2005; Noiseux et al., 2006).”
InfluentialKhatab, S., van Osch, G., Kops, N., Bastiaansen-Jenniskens, Y. M., Bos, P. K., Verhaar, J. A. N., Bernsen, M. R., & van Buul, G. M. (2018) · European Cells and Materials · doi:10.22203/ecm.v036a16 · Cited by 93
Kim, H., Yu, M. R., Lee, H., Kwon, S., Jeon, J. S., Han, D. C., & Noh, H. (2021) · Aging Cell · doi:10.1111/acel.13317 · Cited by 92
“Further, MSCs may accelerate tissue repair via a paracrine mechanism leading to proangiogenic, anti- inflammatory, and antifibrotic effects than directly differentiating into tissue- specific cells (Gnecchi et al., 2005).”
BackgroundYu, W. Y., Sheridan, C., Grierson, I., Mason, S. L., Kearns, V., Lo, A., & Wong, D. (2011) · BioMed Research International · doi:10.1155/2011/412743 · Cited by 98
Human CD34 + Cells in Experimental Myocardial Infarction
Wang, J., Zhang, S., Rabinovich, B. A., Bidaut, L. M., Soghomonyan, S., Alauddin, M. M., Bankson, J. A., Shpall, E. J., Willerson, J. T., Gelovani, J. G., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.221762 · Cited by 89
Exosomes as Potential Alternatives to Stem Cell Therapy in Mediating Cardiac Regeneration
Ong, S., & Wu, J. C. (2015) · Circulation Research · doi:10.1161/circresaha.115.306593 · Cited by 90
“secrete a broad range of cytokines, chemokines, and growth factors that are involved in cardiac repair.(5) Strong support”
BackgroundHu, S., Li, J., Xu, X., Liu, A., He, H., Xu, J., Chen, Q., Liu, S., Liu, L., Qiu, H., et al. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0320-5 · Cited by 86
“Many studies have detected HGF protein in the cell culture medium of MSC [10, 11].”
BackgroundSelf-citationRecent Progress in Stem Cell Modification for Cardiac Regeneration
Lemcke, H., Voronina, N., Steinhoff, G., & David, R. (2018) · Stem Cells International · doi:10.1155/2018/1909346 · Cited by 93
“Importantly, cell engineering-based modifications of MSCs have also been demonstrated to favorably influence the cardioprotective properties of released exosomes [222].”
BackgroundTherapeutic Potential of Extracellular Vesicles for the Treatment of Nerve Disorders
Galieva, L. R., James, V. H., Mukhamedshina, Y. O., & Rizvanov, A. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00163 · Cited by 91
Sicari, B. M., Dearth, C. L., & Badylak, S. F. (2013) · The Anatomical Record · doi:10.1002/ar.22794 · Cited by 96
“…cell transplantation, whether alone or in the context of a TEMC, are most likely associated with a paracrine effect of the donor cells upon the host injured microenvironment (Gnecchi et al., 2005, 2008; Murry et al., 2006; PerezIlzarbe et al., 2008; Arthur et al., 2009; Gharaibeh et al., 2011).”
BackgroundSonic Hedgehog Gene Delivery to the Rodent Heart Promotes Angiogenesis via iNOS/Netrin-1/PKC Pathway
Ahmed, R. P. H., Haider, K. H., Shujia, J., Afzal, M. R., & Ashraf, M. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008576 · Cited by 88
“In addition, BMSCs are excellent carriers of therapeutic genes to the heart [11–13].”
BackgroundMSC Microvesicles for the Treatment of Lung Disease: A New Paradigm for Cell-Free Therapy
Sdrimas, K., & Kourembanas, S. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5784 · Cited by 91
“first proposed that the effect of genetically engineered MSCs takes place in less than 72 h, before any regeneration can take place, and showed that CM from MSCs cultured in vitro have comparable efficacy to whole cell transplantation in preventing ventricular remodeling (29).”
BackgroundOng, S., Huber, B. C., Lee, W. H., Kodo, K., Ebert, A., Ma, Y., Nguyen, P. K. P., Diecke, S., Chen, W.-Y., & Wu, J. C. (2015) · Circulation · doi:10.1161/circulationaha.114.015231 · Cited by 91
Man, K., Barroso, I. A., Brunet, M. Y., Peacock, B., Federici, A., Hoey, D. A., & Cox, S. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020832 · Cited by 93
“The favourable effects once attributed to cells, are now thought to be partly due to the bioactive factors delivered by EVs [18,19].”
BackgroundBakondi, B., Shimada, I. S., Perry, A. S., Munoz, J. R., Ylöstalo, J., Howard, A., Gregory, C. A., & Spees, J. L. (2009) · Molecular Therapy · doi:10.1038/mt.2009.185 · Cited by 92
C-kit+ cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment
Gambini, E., Pompilio, G., Biondi, A., Alamanni, F., Capogrossi, M. C., Agrifoglio, M., & Pesce, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq292 · Cited by 86
Fan, L., Lin, C., Zhuo, S., Chen, L., Liu, N., Luo, Y., Fang, J., Huang, Z., Lin, Y., & Chen, J. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp135 · Cited by 86
“cytokines are also associated with the paracrine effect of MSCs, such as basic fibroblast growth factor, hepatocyte growth factor, and angiopoietin-2.(29,30) To verify whether SVV-engineered MSCs”
BackgroundChen, W., Liu, X., Chen, Q., Bao, C., Zhao, L., Zhu, Z., & Xu, H. H. K. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2395 · Cited by 88
“In addition, under hypoxia, MSCs showed an increased synthesis and secretion of several cytokines, which can inhibit the apoptosis of ECs and accelerate angiogenesis (Gnecchi et al., 2005; Hung et al., 2007).”
BackgroundKim, J., Shapiro, L. H., & Flynn, A. W. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.02.003 · Cited by 85
Developmental origin and lineage plasticity of endogenous cardiac stem cells
Santini, M. P., Forte, E., Harvey, R. P., & Kovacic, J. C. (2016) · Development · doi:10.1242/dev.111591 · Cited by 95
“…trials conducted to date have shown that cell transplantation is generally safe and might trigger beneficial effects, probably as a result of release of growth factors and cytokines/chemokines that favor endogenous tissue re-endothelialization and decreased apoptosis (Gnecchi et al., 2005, 2006).”
BackgroundHersant, B., SidAhmed‐Mezi, M., Braud, L., Jourdan, M., Baba‐Amer, Y., Meningaud, J., & Rodriguez, A. (2019) · Stem Cells International · doi:10.1155/2019/1234263 · Cited by 89
Induced Pluripotent Stem (iPS) Cells Repair and Regenerate Infarcted Myocardium
Singla, D. K., Long, X., Glass, C. E., Singla, R. D., & Yan, B. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2001704 · Cited by 85
Cell-Based Therapy in Cardiac Regeneration: An Overview
Braunwald, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.313484 · Cited by 94
Zhang, W., Liu, L., Huo, Y., Yang, Y., & Wang, Y. (2014) · BioMed Research International · doi:10.1155/2014/462472 · Cited by 86
“However, it has been demonstrated by independent groups that rare MSCs would differentiate into target cells in vivo, and significant therapeutic effects could also be obtained with MSC-conditioned medium without MSCs [29, 31–33].”
BackgroundLi, D., Wang, N., Zhang, L., Hanyu, Z., Xueyuan, B., Fu, B., Shaoyuan, C., Zhang, W., Xuefeng, S., Li, R., et al. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt314 · Cited by 84
“Our finding [33] and those of other researchers suggest that the effect of MSCs is mediated mainly by cytoprotective, antiapoptotic, anti-inflammatory factors [34,35], as well as cellular differentiation [36].”
ResultSelf-citationMoon, H.-H., Joo, M. K., Mok, H., Lee, M., Hwang, K.-C., Kim, S. W., Jeong, J. H., Choi, D., & Kim, S. H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.019 · Cited by 89
“For example, pro-survival gene Akt1-modified MSCs could efficiently inhibit cardiac remodeling and completely normalized cardiac function [8].”
BackgroundMore insight into mesenchymal stem cells and their effects inside the body
Zou, Z., Zhang, Y., Hao, L., Wang, F., Liu, D., Su, Y., & Sun, H. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903456011 · Cited by 88
“It has been confirmed that MSC-CM from akt-modified MSCs protects the myocardium in an animal model of myocardial infarction by intramyocardial injection [43], and attenuates monocyte chemoattractant protein-1 (MCP-1)-caused injury of cultured adult rat cardiomyocytes [44].”
BackgroundCell-based therapies and imaging in cardiology
Bengel, F. M., Schächinger, V., & Dimmeler, S. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1898-5 · Cited by 84
“In line with this discussion, injection of conditioned medium of mesenchymal stem cells has recently been shown to improve neovascularisation and cardiac function [20].”
BackgroundBioengineering approaches to treat the failing heart: from cell biology to 3D printing
Yadid, M., Oved, H., Silberman, E., & Dvir, T. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00603-7 · Cited by 83
Encapsulated mesenchymal stromal cells for in vivo transplantation
Barminko, J., Kim, J. H., Otsuka, S., Gray, A., Schloss, R. S., Grumet, M., & Yarmush, M. L. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23233 · Cited by 87
“Many investigators have suggested that hMSC orchestrate biochemical cues that mitigate fibrosis and promote tissue protection, via secretion of soluble factors (Gnecchi et al. 2005; Hardjo et al. 2009; Kunter et al. 2006; Ortiz et al. 2003; Yagi et al. 2010c).”
BackgroundXing, L., Cui, R., Peng, L., Ma, J., Chen, X. T., Xie, R., & Li, B. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt489 · Cited by 83
Wu, Q., Fang, T., Lang, H., Chen, M., Shi, P., Pang, X., & Qi, G. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2897 · Cited by 88
“In vivo studies demonstrated that there were few differentiated cells being tested and the tissue concentrations of growth factors were significantly increased in injured areas treated with stem cells in transplanted models (10,27).”
BackgroundA Role for Exosomes in Craniofacial Tissue Engineering and Regeneration
Cooper, L. F., Ravindran, S., Huang, C.-C., & Kang, M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01569 · Cited by 90
“Earlier studies of myocardial regeneration demonstrated that the conditioned media of MSCs could support myocardial regeneration in vivo (Gnecchi et al., 2005).”
BackgroundMesenchymal stem cells from different sources and their derived exosomes: A pre-clinical perspective
Álvarez‐Viejo, M. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i2.100 · Cited by 87
Defining human mesenchymal stem cell efficacy in vivo
Bonfield, T. L., Nolan, M., Lennon, D. P., & Caplan, A. I. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-51 · Cited by 82
“hMSCs in culture secrete a variety of molecules, both bioactive and extracellular matrix, in response to their local environment and their activity status [7,8,50].”
BackgroundLaggner, M., Gugerell, A., Bachmann, C., Hofbauer, H., Vorstandlechner, V., Seibold, M., Gouya Lechner, G., Peterbauer, A., Madlener, S., Demyanets, S., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1524-2 · Cited by 76
DPSC-Derived Extracellular Vesicles Promote Rat Jawbone Regeneration
Lee, A. E., Choi, J., Shi, S., He, P., Zhang, Q. Z., & Le, A. D. (2022) · Journal of Dental Research · doi:10.1177/00220345221133716 · Cited by 84
“MSCs achieve therapeutic effects via their paracrine secretion of a panel of biological factors (Gnecchi et al. 2005; Gnecchi et al. 2016).”
BackgroundKim, S., Han, J. W., Lee, J. Y., Choi, Y. J., Sohn, Y.-D., Song, M., & Yoon, Y.-S. (2014) · Cell Transplantation · doi:10.3727/096368914x682792 · Cited by 83
“Prior studies suggested the role of AKT1 in paracrine activities of MSCs (15,38,42) or angiogenic activities in stromal or tumor cells (24), but no studies have explored these roles in relation to diabetes.”
Huang, M., Nguyen, P. K. P., Jia, F., Hu, S., Gong, Y., de Almeida, P. E., Wang, L., Nag, D., Kay, M. A., Giaccia, A. J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.014019 · Cited by 83
Microvesicles as mediators of tissue regeneration
Sabin, K., & Kikyo, N. (2014) · Translational Research · doi:10.1016/j.trsl.2013.10.005 · Cited by 81
Gharaibeh, B., Lavasani, M., Cummins, J. H., & Huard, J. (2011) · Stem Cell Research & Therapy · doi:10.1186/scrt72 · Cited by 81
“Th e most promising cell populations evaluated to date include skeletal muscle myoblasts [20-23], murine embryonic stem cells [24,25], bone marrow (BM)-derived stem cells, mesenchymal stem cells (MSCs) [17,26-28], purifi ed (enriched) hematopoietic stem cells [29-31], blood- and BM-derived endothelial progenitor cells…”
BackgroundExploiting paracrine mechanisms of tissue regeneration to repair damaged organs
Anthony, D. F., & Shiels, P. G. (2013) · Transplantation Research · doi:10.1186/2047-1440-2-10 · Cited by 83
“A similar study employing MSCs engineered to overexpress Akt also successfully showed, in vitro and in vivo, the cytoprotective effects of these engineered cells on ischaemic hearts [52].”
BackgroundInnovative Hydrogel Design: Tailoring Immunomodulation for Optimal Chronic Wound Recovery
Lai, C., Chen, W., Yuan, Q., Xu, D., Lai, Y., & He, S. (2024) · Advanced Science · doi:10.1002/advs.202412360 · Cited by 94
Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells
Singla, D. K., & McDonald, D. E. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00431.2007 · Cited by 79
“Our data are consistent with recent findings suggesting that factors released from hypoxia-induced Akt-mesenchymal stem cells subjected to hypoxia inhibit apoptosis in isolated cardiomyocytes (8).”
ResultWhittaker, T. E., Nagelkerke, A., Nele, V., Kauscher, U., & Stevens, M. M. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1807674 · Cited by 79
Tieu, A., Hu, K., Gnyra, C., Montroy, J. R., Fergusson, D. A., Allan, D., Stewart, D. J., Thébaud, B., & Lalu, M. M. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12141 · Cited by 83
“…that MSCs exert their therapeutic effects at least in part by secretion of extracellular vesicles (EVs), which may represent a more robust therapeutic product than delivery of intact cells (Akyurekli et al., 2015; Allan et al., 2019; Börger et al., 2017; Colombo et al., 2014; Gnecchi et al., 2005).”
Stem cells and regenerative medicine — future perspectives
Brunt, K. R., Weisel, R. D., & Li, R. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-007 · Cited by 93
“In lieu of differentiation, bone marrow stem cells produce humoral factors that increase host cell survival, promote angiogenesis, reactivate cardiomyocyte proliferation, or stimulate resident stem cells (Gnecchi et al. 2005; Chimenti et al. 2010; Loffredo et al. 2011).”
Cell-enhancement strategies for the treatment of ischemic heart disease
Seeger, F. H., Zeiher, A. M., & Dimmeler, S. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0734 · Cited by 79
“Conditioned medium from Akt-transduced mesenchymal stem cells was enriched for cytoprotective factors, which might indirectly improve heart function”
BackgroundThe Regenerative Role of the Fetal and Adult Stem Cell Secretome
Bollini, S., Gentili, C., Tasso, R., & Cancedda, R. (2013) · Journal of Clinical Medicine · doi:10.3390/jcm2040302 · Cited by 84
“The cardioprotective role of the adult MSC secretome was further confirmed by exposing cardiomyocytes to genetically modified MSC-conditioned medium under hypoxic conditions [65]; in particular, MSC-conditioned medium also promoted in vitro proliferation and migration of endothelial cells in a dose-dependent manner wi…”
BackgroundKim, S.-W., Zhang, H.-Z., Kim, C. E., An, H. S., Kim, J.-M., & Kim, M. H. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr328 · Cited by 76
Protection of Brain Injury by Amniotic Mesenchymal Stromal Cell-Secreted Metabolites
Pischiutta, F., Brunelli, L., Romele, P., Silini, A. R., Sammali, E., Paracchini, L., Marchini, S., Talamini, L., Bigini, P., Boncoraglio, G. B., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001864 · Cited by 80
Zhu, Z., Zhang, Y., Zhang, Y., Zhang, H., Liu, W., Zhang, N., Zhang, X., Zhou, G., Wu, L., Hua, K., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey344 · Cited by 86
“It is generally considered that transplanted hucMSC promote tissue repair mainly through soluble factors (Gnecchi et al., 2005).”
Background
Metadata
- Authors
- Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., & Dzau, V. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Dzau, Victor J
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-04
- Volume
- 11
- Issue
- 4
- Pages
- 367-368
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2067591094
- Cited by
- 1,677
- References
- 7
- Citations by year
- 2026: 31 · 2025: 35 · 2024: 49 · 2023: 55 · 2022: 67 · 2021: 86 · 2020: 91 · 2019: 69 · 2018: 74 · 2017: 87 · 2016: 95 · 2015: 89 · 2014: 81 · 2013: 88 · 2012: 106
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institutes of Health (1z01hl005320-01)
- National Heart, Lung, and Blood Institute (HL 73219, HL-58516, HL 72010, R01HL063985, HL 5320, R01HL058516, R01HL072010, HL-35610, R01HL073219, HL 63985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- paracrine signaling, mesenchymal stem cells, Akt signaling, myocardial ischemia, cardioprotection, cell therapy, exosomes, secretome
- MeSH terms
- Animals, Cells, Cultured, Myocardial Infarction, Myocardium, Proto-Oncogene Proteins, Cell Hypoxia, Bone Marrow Transplantation, Culture Media, Conditioned, Apoptosis, Protein Serine-Threonine Kinases, Intercellular Signaling Peptides and Proteins, Mesenchymal Stem Cell Transplantation, Green Fluorescent Proteins, Proto-Oncogene Proteins c-akt, Rats, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.